Correlation Between COVID-19 Severity, Body Mass Index and Radiological Hepatic Morphology/Correlación entre la Gravedad de COVID-19, el Índice de Masa Corporal y la Morfología Hepática Radiológica

Obesity and fatty liver steatosis are already considered metabolic risk factors which may aggravate the severity of COVID-19. This study aims to investigate the correlation between COVID-19 severity, obesity, and liver steatosis and fibrosis. 230 consecutive patients with laboratory-confirmed COVID-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of morphology 2021-07, Vol.39 (4), p.1096
Hauptverfasser: Qandeel, Haitham, Tayyem, Raed, Fataftah, Jehad, Qasem, Muhannad, Sami, Rawan, Ashour, Haneen, Hasanat, Subreen, Tayyem, Rand, Alqassieh, Rami
Format: Artikel
Sprache:spa
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Obesity and fatty liver steatosis are already considered metabolic risk factors which may aggravate the severity of COVID-19. This study aims to investigate the correlation between COVID-19 severity, obesity, and liver steatosis and fibrosis. 230 consecutive patients with laboratory-confirmed COVID-19 aged between 15 and 84? years, admitted to a hospital devoted to COVID-19 patients, were enrolled in the study. COVID-19 severity was classified as severe versus non-severe based on admission to ICU. Obesity was assessed by Body Mass Index (BMI). CT-scan was used to check for the liver steatosis. Fibrosis-4 score was calculated. The study was conducted in March-May 2020. Obesity strongly and positively correlated with severe COVID-19 illness r: 0.760 (P
ISSN:0717-9367